Kuros Biosciences AG
CSBTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $17 | $14 | $24 | $29 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $15 | $6 | $3 | $2 |
| Inventory | $9 | $5 | $3 | $2 |
| Other Curr. Assets | $3 | $2 | $1 | $1 |
| Total Curr. Assets | $45 | $27 | $31 | $33 |
| Property Plant & Equip (Net) | $3 | $3 | $2 | $2 |
| Goodwill | $19 | $24 | $29 | $33 |
| Intangibles | $15 | $17 | $19 | $23 |
| Long-Term Investments | $0 | $17 | $51 | $53 |
| Tax Assets | $2 | $0 | $1 | $5 |
| Other NC Assets | $0 | -$16 | -$51 | -$58 |
| Total NC Assets | $40 | $44 | $52 | $58 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $85 | $71 | $83 | $91 |
| Liabilities | – | – | – | – |
| Payables | $7 | $1 | $1 | $1 |
| Short-Term Debt | $1 | $1 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $13 | $11 | $11 | $10 |
| Total Curr. Liab. | $21 | $13 | $13 | $11 |
| LT Debt | $1 | $2 | $1 | $2 |
| Deferred Rev, NC | $0 | -$2 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $4 | $5 | $1 |
| Other NC Liab. | $3 | $3 | $0 | $0 |
| Total NC Liab. | $5 | $2 | $1 | $3 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $2 | $2 |
| Total Liabilities | $26 | $15 | $14 | $14 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $4 | $4 | $4 | $3 |
| Retained Earnings | -$45 | -$42 | -$116 | -$101 |
| AOCI | $0 | $22 | $0 | $0 |
| Other Equity | $100 | $73 | $181 | $175 |
| Total Equity | $59 | $57 | $69 | $77 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $85 | $71 | $83 | $91 |
| Net Debt | -$16 | -$12 | -$22 | -$26 |